PI3K/mTOR Inhibitor-6
PI3K/mTOR Inhibitor-6 (Compound 19c) is a potent and dual inhibitor of PI3K/mTOR. PI3K/mTOR Inhibitor-6 displays better stability in artificial gastric fluids than gedatolisib. PI3K/mTOR Inhibitor-6 significantly suppresses the PI3K/Akt/mTOR signaling pathway at 10 μM. PI3K/mTOR Inhibitor-6 has the potential for the research of cancer diseases[1].
Product Specifications
CAS Number
2456295-59-1
UNSPSC
12352005
Target
MTOR; PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3k-mtor-inhibitor-6.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H]1N(C(C2=CC=C3C(NC(NC4=CC=C(C5=NC(N6CCOCC6)=NC(N7CCOCC7)=N5)C=C4)=N3)=C2)=O)CCC1)N
Molecular Formula
C30H34N10O4
Molecular Weight
598.66
References & Citations
[1]Wang L, et al. Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors. Eur J Med Chem. 2020 Oct 15;204:112637
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EKU10521 96 Tests
Rat Apolipoprotein B100 (APOB100) Wide-range ELISA Kit
Sign In for Pricing
View Details TRC-B286160-50MG 50 mg
N-Benzyloxycarbonyl-O-(2-chloro-2,2-diphenyl)acetyl Nortropine
Sign In for Pricing
View Details